참고문헌
- Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998;159:1163-7. https://doi.org/10.1016/S0022-5347(01)63541-9
- Uchida K, Miyao N, Masumori N, et al. Recurrence of renal cell carcinoma more than 5 years after nephrectomy. Int J Urol 2002;9:19-23. https://doi.org/10.1046/j.1442-2042.2002.00418.x
- Juusela H, Malmio K, Alfthan O, Oravisto KJ. Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol 1977;11:277-81. https://doi.org/10.3109/00365597709179965
- van der Werf-Messing B. Proceedings: carcinoma of the kidney. Cancer 1973;32:1056-61. https://doi.org/10.1002/1097-0142(197311)32:5<1056::AID-CNCR2820320505>3.0.CO;2-M
- Nguyen QN, Shiu AS, Rhines LD, et al. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010;76:1185-92. https://doi.org/10.1016/j.ijrobp.2009.03.062
- Balagamwala EH, Angelov L, Koyfman SA, et al. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma. J Neurosurg Spine 2012;17:556-64. https://doi.org/10.3171/2012.8.SPINE12303
- Ghia AJ, Chang EL, Bishop AJ, et al. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. J Neurosurg Spine 2016;24:829-36. https://doi.org/10.3171/2015.8.SPINE15844
- Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996;335:865-75. https://doi.org/10.1056/NEJM199609193351207
- Mattei J, da Silva RD, Sehrt D, Molina WR, Kim FJ. Targeted therapy in metastatic renal carcinoma. Cancer Lett 2014;343:156-60. https://doi.org/10.1016/j.canlet.2013.09.038
- De Wolf K, Vermaelen K, De Meerleer G, Lambrecht BN, Ost P. The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy. Oncoimmunology 2015;4:e1042198. https://doi.org/10.1080/2162402X.2015.1042198
- Kao J, Packer S, Vu HL, et al. Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer 2009;115:3571-80. https://doi.org/10.1002/cncr.24412
- Tong CC, Ko EC, Sung MW, et al. Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases. PLoS One 2012;7:e36979. https://doi.org/10.1371/journal.pone.0036979
- Wilson D, Hiller L, Gray L, Grainger M, Stirling A, James N. The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma. Clin Oncol (R Coll Radiol) 2003;15:400-7. https://doi.org/10.1016/S0936-6555(03)00164-X
- Thibault I, Chang EL, Sheehan J, et al. Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro- Oncology (SPINO) group. Lancet Oncol 2015;16:e595-603. https://doi.org/10.1016/S1470-2045(15)00166-7
- Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidencebased approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) 2010;35:E1221-9. https://doi.org/10.1097/BRS.0b013e3181e16ae2
- DiBiase SJ, Valicenti RK, Schultz D, Xie Y, Gomella LG, Corn BW. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol 1997;158(3 Pt 1):746-9. https://doi.org/10.1016/S0022-5347(01)64305-2
- Jhaveri PM, Teh BS, Paulino AC, et al. A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases. Acta Oncol 2012;51:584-8. https://doi.org/10.3109/0284186X.2011.652741
- Amini A, Altoos B, Bourlon MT, et al. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: is RCC truly radioresistant? Pract Radiat Oncol 2015;5:e589-96. https://doi.org/10.1016/j.prro.2015.05.004
- Sohn S, Chung CK, Sohn MJ, et al. Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study. J Neurooncol 2014;119:121-8. https://doi.org/10.1007/s11060-014-1455-9
- Geels P, Eisenhauer E, Bezjak A, Zee B, Day A. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 2000;18:2395-405. https://doi.org/10.1200/JCO.2000.18.12.2395
- Vakaet LA, Boterberg T. Pain control by ionizing radiation of bone metastasis. Int J Dev Biol 2004;48:599-606. https://doi.org/10.1387/ijdb.041817lv
피인용 문헌
- The Challenges of Renal Cell Carcinoma Metastatic to the Spine: A Systematic Review of Survival and Treatment vol.8, pp.5, 2016, https://doi.org/10.1177/2192568217737777
- The 18 F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomes vol.13, pp.9, 2016, https://doi.org/10.1371/journal.pone.0204918
- Role of metastasis‐directed treatment in kidney cancer vol.124, pp.18, 2018, https://doi.org/10.1002/cncr.31341
- Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study vol.4, pp.5, 2019, https://doi.org/10.1136/esmoopen-2019-000535
- Patient Characteristics Following Surgery for Spinal Metastases: A Multicenter Retrospective Study vol.11, pp.6, 2019, https://doi.org/10.1111/os.12551